Covered recipient · General Payments record
KEITH I STOKES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$550,561.49
- Reported across 360 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $113,500.00 | 49 |
| Food and Beverage | $205.18 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $113,500.00 | 49 |
| Merck Sharp & Dohme Corporation | $98.25 | 1 |
| Gilead Sciences, Inc. | $74.32 | 3 |
| Janssen Pharmaceuticals, Inc | $19.34 | 1 |
| ViiV Healthcare Company | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Plasma Inc. | $2,000.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659189 | CMS |
| CSL Plasma Inc. | $2,750.00 | 01/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659191 | CMS |
| CSL Plasma Inc. | $2,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659193 | CMS |
| CSL Plasma Inc. | $2,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659357 | CMS |
| CSL Plasma Inc. | $2,000.00 | 02/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659195 | CMS |
| CSL Plasma Inc. | $2,250.00 | 02/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659197 | CMS |
| CSL Plasma Inc. | $2,250.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659199 | CMS |
| CSL Plasma Inc. | $2,000.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659201 | CMS |
| CSL Plasma Inc. | $2,250.00 | 02/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659203 | CMS |
| CSL Plasma Inc. | $2,000.00 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659205 | CMS |
| CSL Plasma Inc. | $2,250.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659207 | CMS |
| CSL Plasma Inc. | $2,000.00 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659209 | CMS |
| CSL Plasma Inc. | $2,500.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659211 | CMS |
| CSL Plasma Inc. | $2,250.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659213 | CMS |
| CSL Plasma Inc. | $2,750.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659215 | CMS |
| CSL Plasma Inc. | $2,500.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659217 | CMS |
| CSL Plasma Inc. | $2,250.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659219 | CMS |
| CSL Plasma Inc. | $2,000.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659221 | CMS |
| CSL Plasma Inc. | $2,000.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659359 | CMS |
| CSL Plasma Inc. | $2,500.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659383 | CMS |
| CSL Plasma Inc. | $2,500.00 | 05/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659385 | CMS |
| CSL Plasma Inc. | $2,500.00 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659387 | CMS |
| CSL Plasma Inc. | $2,500.00 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659389 | CMS |
| CSL Plasma Inc. | $2,250.00 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659391 | CMS |
| CSL Plasma Inc. | $2,500.00 | 06/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659393 | CMS |
| CSL Plasma Inc. | $2,250.00 | 06/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659395 | CMS |
| CSL Plasma Inc. | $2,500.00 | 06/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134659517 | CMS |
| CSL Plasma Inc. | $2,500.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141864 | CMS |
| CSL Plasma Inc. | $2,000.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141866 | CMS |
| CSL Plasma Inc. | $2,000.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141870 | CMS |
| CSL Plasma Inc. | $2,500.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141872 | CMS |
| CSL Plasma Inc. | $2,250.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141874 | CMS |
| CSL Plasma Inc. | $2,500.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141880 | CMS |
| CSL Plasma Inc. | $2,250.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141882 | CMS |
| CSL Plasma Inc. | $2,000.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141884 | CMS |
| CSL Plasma Inc. | $3,000.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141888 | CMS |
| CSL Plasma Inc. | $2,250.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141892 | CMS |
| CSL Plasma Inc. | $2,500.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141894 | CMS |
| CSL Plasma Inc. | $3,000.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141896 | CMS |
| CSL Plasma Inc. | $2,750.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141898 | CMS |
| CSL Plasma Inc. | $2,000.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141900 | CMS |
| CSL Plasma Inc. | $2,250.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141902 | CMS |
| CSL Plasma Inc. | $2,500.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141908 | CMS |
| CSL Plasma Inc. | $2,000.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141910 | CMS |
| CSL Plasma Inc. | $2,500.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141912 | CMS |
| CSL Plasma Inc. | $2,750.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141914 | CMS |
| CSL Plasma Inc. | $2,500.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141930 | CMS |
| CSL Plasma Inc. | $2,000.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141920 | CMS |
| CSL Plasma Inc. | $2,000.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142141934 | CMS |
| Gilead Sciences, Inc. | $35.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133742537 | CMS |
| Gilead Sciences, Inc. | $25.91 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133742539 | CMS |
| Gilead Sciences, Inc. | $13.41 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133742541 | CMS |
| Janssen Pharmaceuticals, Inc | $19.34 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078066770 | CMS |
| Merck Sharp & Dohme LLC | $98.25 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141585918 | CMS |
| ViiV Healthcare Company | $13.27 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112742609 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.